CLINICAL_TRIALS
trial_result
· 2013-10-29
Clinical Trial Update: Ambroxol Lozenges 20mg in Relieving the Pain of Sore Throat in Adolescent Patients With Acute Viral Pharyngitis [Phase 3]
Summary
Phase 3 trial evaluating ambroxol lozenges 20 mg for relief of sore throat in adolescents with acute viral pharyngitis; the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pharyngitis | Phase 3 | Status: COMPLETED